165 related articles for article (PubMed ID: 30361044)
1. Combination of line immunoassays Mikrogen recomLine CMV IgG and recomLine CMV IgG Avidity helps to date the onset of CMV primary infection.
Delforge ML; Eykmans J; Steensels D; Costa E; Donner C; Montesinos I
Diagn Microbiol Infect Dis; 2019 Mar; 93(3):208-212. PubMed ID: 30361044
[TBL] [Abstract][Full Text] [Related]
2. The value of CMV IgG avidity and immunoblot for timing the onset of primary CMV infection in pregnancy.
Enders G; Daiminger A; Bäder U; Exler S; Schimpf Y; Enders M
J Clin Virol; 2013 Feb; 56(2):102-7. PubMed ID: 23153820
[TBL] [Abstract][Full Text] [Related]
3. Improvement of cytomegalovirus avidity testing by adjusting the concentration of CMV-specific IgG in test samples.
Dangel V; Bäder U; Enders G
J Clin Virol; 2006 Mar; 35(3):303-9. PubMed ID: 16298547
[TBL] [Abstract][Full Text] [Related]
4. Improving diagnosis of primary cytomegalovirus infection in pregnant women using immunoblots.
Rajasekariah H; Scott G; Robertson PW; Rawlinson WD
J Med Virol; 2013 Feb; 85(2):315-9. PubMed ID: 23171986
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the Abbott AxSYM cytomegalovirus (CMV) immunoglobulin M (IgM) assay in conjunction with other CMV IgM tests and a CMV IgG avidity assay.
Lazzarotto T; Galli C; Pulvirenti R; Rescaldani R; Vezzo R; La Gioia A; Martinelli C; La Rocca S; Agresti G; Grillner L; Nordin M; van Ranst M; Combs B; Maine GT; Landini MP
Clin Diagn Lab Immunol; 2001 Jan; 8(1):196-8. PubMed ID: 11139220
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the new architect cytomegalovirus immunoglobulin M (IgM), IgG, and IgG avidity assays.
Lagrou K; Bodeus M; Van Ranst M; Goubau P
J Clin Microbiol; 2009 Jun; 47(6):1695-9. PubMed ID: 19339470
[TBL] [Abstract][Full Text] [Related]
7. Re-evaluation of the VIDAS(®) cytomegalovirus (CMV) IgG avidity assay: determination of new cut-off values based on the study of kinetics of CMV-IgG maturation.
Vauloup-Fellous C; Berth M; Heskia F; Dugua JM; Grangeot-Keros L
J Clin Virol; 2013 Feb; 56(2):118-23. PubMed ID: 23182774
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the indirect and IgM-capture anti-human cytomegalovirus IgM ELISA methods as confirmed by cytomegalovirus IgG avidity.
Ikuta K; Koshizuka T; Kanno R; Inoue N; Kubo T; Koyano S; Suzutani T
Microbiol Immunol; 2019 May; 63(5):172-178. PubMed ID: 31012489
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the LIAISON(®) CMV IgG Avidity II and the VIDAS(®) CMV IgG Avidity II assays for the diagnosis of primary infection in pregnant women.
Sellier Y; Guilleminot T; Ville Y; Leruez-Ville M
J Clin Virol; 2015 Nov; 72():46-8. PubMed ID: 26397203
[TBL] [Abstract][Full Text] [Related]
10. National prevalence estimates for cytomegalovirus IgM and IgG avidity and association between high IgM antibody titer and low IgG avidity.
Dollard SC; Staras SA; Amin MM; Schmid DS; Cannon MJ
Clin Vaccine Immunol; 2011 Nov; 18(11):1895-9. PubMed ID: 21918114
[TBL] [Abstract][Full Text] [Related]
11. Multicenter evaluation of a rapid and convenient method for determination of cytomegalovirus immunoglobulin G avidity.
Baccard-Longere M; Freymuth F; Cointe D; Seigneurin JM; Grangeot-Keros L
Clin Diagn Lab Immunol; 2001 Mar; 8(2):429-31. PubMed ID: 11238233
[TBL] [Abstract][Full Text] [Related]
12. Role of cytomegalovirus (CMV) IgG avidity testing in diagnosing primary CMV infection during pregnancy.
Prince HE; Lapé-Nixon M
Clin Vaccine Immunol; 2014 Oct; 21(10):1377-84. PubMed ID: 25165026
[TBL] [Abstract][Full Text] [Related]
13. Validation of an in-house assay for cytomegalovirus immunoglobulin G (CMV IgG) avidity and relationship of avidity to CMV IgM levels.
Prince HE; Leber AL
Clin Diagn Lab Immunol; 2002 Jul; 9(4):824-7. PubMed ID: 12093680
[TBL] [Abstract][Full Text] [Related]
14. Maternal immunoglobulin G avidity as a diagnostic tool to identify pregnant women at risk of congenital cytomegalovirus infection.
Kaneko M; Ohhashi M; Minematsu T; Muraoka J; Kusumoto K; Sameshima H
J Infect Chemother; 2017 Mar; 23(3):173-176. PubMed ID: 28034524
[TBL] [Abstract][Full Text] [Related]
15. Potential impact of different cytomegalovirus (CMV) IgM assays on an algorithm requiring IgM reactivity as a criterion for measuring CMV IgG avidity.
Prince HE; Lapé-Nixon M; Brenner A; Pitstick N; Couturier MR
Clin Vaccine Immunol; 2014 Jun; 21(6):813-6. PubMed ID: 24671558
[TBL] [Abstract][Full Text] [Related]
16. Value of cytomegalovirus (CMV) IgG avidity index for the diagnosis of primary CMV infection in pregnant women.
Grangeot-Keros L; Mayaux MJ; Lebon P; Freymuth F; Eugene G; Stricker R; Dussaix E
J Infect Dis; 1997 Apr; 175(4):944-6. PubMed ID: 9086155
[TBL] [Abstract][Full Text] [Related]
17. Serologic screening of pregnant Korean women for primary human cytomegalovirus infection using IgG avidity test.
Seo S; Cho Y; Park J
Korean J Lab Med; 2009 Dec; 29(6):557-62. PubMed ID: 20046088
[TBL] [Abstract][Full Text] [Related]
18. Primary cytomegalovirus infection in pregnant Egyptian women confirmed by cytomegalovirus IgG avidity testing.
Kamel N; Metwally L; Gomaa N; Sayed Ahmed WA; Lotfi M; Younis S
Med Princ Pract; 2014; 23(1):29-33. PubMed ID: 24052007
[TBL] [Abstract][Full Text] [Related]
19. Low IgG avidity and ultrasound fetal abnormality predict congenital cytomegalovirus infection.
Sonoyama A; Ebina Y; Morioka I; Tanimura K; Morizane M; Tairaku S; Minematsu T; Inoue N; Yamada H
J Med Virol; 2012 Dec; 84(12):1928-33. PubMed ID: 23080498
[TBL] [Abstract][Full Text] [Related]
20. Performance of a cytomegalovirus IgG enzyme immunoassay kit modified to measure avidity.
Prince HE; Lapé-Nixon M; Novak-Weekley SM
Clin Vaccine Immunol; 2014 Jun; 21(6):808-12. PubMed ID: 24671557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]